We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.38%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HERA
126
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$5.06M 0.03%
500,000
GSQD
127
DELISTED
G Squared Ascend I Inc.
GSQD
$5.05M 0.03%
500,000
CLAA
128
DELISTED
Colonnade Acquisition Corp. II
CLAA
$5.04M 0.03%
500,000
ALVO icon
129
Alvotech
ALVO
$1.5B
$5M 0.03%
500,000
GHIX
130
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$4.96M 0.03%
500,000
GBIO
131
DELISTED
Generation Bio
GBIO
$4.91M 0.03%
124,938
-125,062
-50% -$6.57M
DGNU
132
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$4.77M 0.03%
484,709
SCOB
133
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$4.56M 0.03%
450,000
LDHA
134
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$4.4M 0.03%
436,702
VPCB
135
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$4.3M 0.03%
425,000
SVFA
136
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$4.3M 0.03%
425,000
BPMC
137
DELISTED
Blueprint Medicines
BPMC
$4.12M 0.02%
+94,000
New +$4.51M
LGVC
138
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$4.1M 0.02%
400,000
IPVF
139
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$4.07M 0.02%
400,000
NUVB icon
140
Nuvation Bio
NUVB
$2.43B
$4.07M 0.02%
2,117,600
-782,400
-27% -$1.58M
FRSG
141
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$4.02M 0.02%
400,000
CITE
142
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$3.62M 0.02%
350,000
VMGA
143
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$3.57M 0.02%
350,000
UTAA
144
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$3.51M 0.02%
344,100
SPCM
145
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$3.26M 0.02%
300,000
BCSA
146
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$3.09M 0.02%
300,000
LGAC
147
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$3.03M 0.02%
300,000
LBPH
148
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$2.64M 0.02%
810,500
LOKM
149
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$2.51M 0.01%
250,000
ANAC
150
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$2.02M 0.01%
200,000

Similar funds

Thomas Steyer's Q4 2022 Portfolio in Review

As of Q4 2022, Thomas Steyer held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Thomas Steyer withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Intuit worth $351M.

  • Thomas Steyer's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Thomas Steyer added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Thomas Steyer's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Thomas Steyer fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Thomas Steyer's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Thomas Steyer opened 13 new positions and closed 80 in Q4 2022.
  • Thomas Steyer's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.